Disease management in ulcer disease

Scandinavian Journal of Gastroenterology, Supplement

Volumn 33, Issue 34, 1999, Pages 23-28

  De Boer, W A ^a   Joosen, E A M ^a  

^a ST ANNA HOSPITAL   (Netherlands)

Author keywords

'Test and treat' strategy; Cost effectiveness; Disease management; Helicobacter pylori; Non ulcer dyspepsia; Peptic ulcer; Therapy

Indexed keywords

ANTACID AGENT; ANTIBIOTIC AGENT; CLARITHROMYCIN; HISTAMINE H2 RECEPTOR ANTAGONIST; METRONIDAZOLE; VACCINE; ANTIINFECTIVE AGENT; ANTIULCER AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; COST EFFECTIVENESS ANALYSIS; DYSPEPSIA; ENDOSCOPY; GRAM NEGATIVE INFECTION; HEALTH CARE COST; HELICOBACTER PYLORI; HUMAN; PEPTIC ULCER; PRIORITY JOURNAL; QUALITY OF LIFE; SEROLOGY; COST BENEFIT ANALYSIS; DRUG COMBINATION; ECONOMICS; HEALTH; HELICOBACTER INFECTION; INCIDENCE; REVIEW; TREATMENT OUTCOME;

ANTI-INFECTIVE AGENTS; ANTI-ULCER AGENTS; COST-BENEFIT ANALYSIS; DRUG THERAPY, COMBINATION; HELICOBACTER INFECTIONS; HUMANS; INCIDENCE; PEPTIC ULCER; QUALITY OF LIFE; TREATMENT OUTCOME; WORLD HEALTH;

EID: 0032612810     PISSN: 00855928     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Boath EH, Blenkinsopp A. The rise and rise of proton pump inhibitor drugs: patients' perspectives. Soc Sci Med 1997;45:1571-9.
2. Martin RM, Lim AG, Kerry SM, Hilton SR. Trends in prescribing H2 receptor antagonists and proton pump inhibitors in primary care. Aliment Pharmacol Ther 1998;12:797-805.
3. Newton M, Smith G, Burnham WR, Nocholls C, So B. Hospital use of proton pump inhibitors: a completed audit in the introduction of a prescribing protocol on in-patients prescriptions. Gut 1998;42 Suppl 1:A69.
4. Bodger K, Daly MJ, Heatley RV. Clinical economics review: Helicobacter pylori associated peptic ulcer disease. Aliment Pharmacol Ther 1997;11:273-82.
5. Macri G, Milani S, Surrenti E, Passaleva MT, Salvadori G, Surrenti C. Eradication of Helicobacter pylori reduces the rate of duodenal ulcer rebleeding: a long-term follow-up study. Am J Gastroenterol 1998;93:925-7.
6. Hirth RA, Fendrick AM, Chernew ME. Specialist and generalist physicians' adoption of antibiotic therapy to eradicate Helicobacter pylori infection. Med Care 1996;34:1199-204.
7. van der Hulst RWM, Rauws EAJ, Koycu B, et al. Helicobacter reinfection is virtually absent after successful eradication. J Infect Dis 1997;176:196-200.
8. Wilhelmsen I. Quality of life and Helicobacter pylori eradication. Scand J Gastroenterol 1996;31 Suppl 221:18-20.
9. Neil GA, and the Ad Hoc Committee on FDA-Related Matters. Do ulcers burn out or burn on? Managing duodenal ulcer diathesis in the Helicobacter pylori era. Am J Gastroenterol 1997;92:387-92.
10. Fendrick AM, McCort JT, Chernew ME, Hirth RA, Patel C, Bloom BS. Immediate eradication of Helicobacter pylori in patients with previously documented peptic ulcer disease: clinical and economic effects. Am J Gastroenterol 1997;92:2017-24.
11. Veldhuyzen van Zanten SJO. The role of Helicobacter pylori infection in non-ulcer dyspepsia. Aliment Pharmacol Ther 1997;11 Suppl 1:63-9.
12. Megraud F. Transmission of Helicobacter pylori: faecal-oral versus oral-oral route. Aliment Pharmacol Ther 1995;9 Suppl 2:85-91.
13. Sipponen P. Helicobacter pylori gastritis - Epidemiology. J Gastroenterol 1997;32:273-7.
14. Roosendaal R, Kuipers EJ, Buitenwerf J, et al. Helicobacter pylori and the birth cohort effect: evidence of a continuous decrease of infection rates in childhood. Am J Gastroenterol 1997;92:1480-2.
15. de Boer WA, van de Wouw BAM, de Vos RJ, Jansz AR, Wijn PFF. Seroprevalence of Helicobacter pylori infection and presence of dyspepsia in military recruits in The Netherlands. In: de Boer WA, Helicobacter pylori. Studies on epidemiology, diagnosis and therapy [Thesis]. University of Amsterdam, 1996. p. 9-16.
16. Sipponen P, Helske T, Jarvinen P, Hyvarinen H, Seppala K, Siurala M. Fall in prevalence of chronic gastritis over 15 years: analysis of outpatient series in Finland from 1977, 1985 and 1992. Gut 1994;35:1167-71.
17. Kosunen TU, Aromaa A, Knekt P, et al. Helicobacter antibodies in 1973 and 1994 in the adult population of Vammala, Finland. Epidemiol Infect 1997;119:29-34.
18. Bardhan PK. Epidemiological features of Helicobacter pylori infection in developing countries. Clin Infect Dis 1997;25:973-8.
19. van Nispen CHM, Smout AJPM. Prevalence of Helicobacter pylori in an asymptomatic population in The Netherlands. Eur J Gastroenterol Hepatol 1997;9:A43-4.